Found 1304 clinical trials
Attentional Performance in Parkinson Disease
Design Participants will be screened with medical and neurological history and exam, and medicine review. Participants will have 1 study visit. It will last 7-8 hours.
- 0 views
- 19 Feb, 2024
Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study
The 2019-2020 coronavirus pandemic has had far-reaching consequences beyond the spread of the disease. Quarantine measures during a public health pandemic can be particularly detrimental to urban poor families and affect the dietary diversity and food security. This can disproportionately affect young children aged 6 and below, and severely impact …
- 0 views
- 19 Feb, 2024
Cardiovascular Consequences After COVID-19
The occurrence of cardiovascular complications in SARS-CoV-2 infections appears to be more frequent than in other viral respiratory infections, probably due to a singular pathophysiology of this coronavirus. The lack of characterization of cardiovascular damages linked to Covid-19 could have medium and long-term consequences on the prognosis of patients.
- 0 views
- 19 Feb, 2024
Comparison Between the Old Diagnostic Tools for Paediatric Undernutrition and the HAS Recommendations
Until now, there has been no national consensus on the criteria to be used to diagnose paediatric undernutrition. Until now, assessment focused on a range of non-consensus arguments that allowed the health care team to make its diagnosis.
- 0 views
- 19 Feb, 2024
Direct Effect of Caffeine on Diaphragmatic Muscles
Right and left sides of diaphragm thickness are being measured by two clinicians on B mode ultrasound by anterior subcostal view. The velocity before and after caffeine administration will be calculated, dividing excursion frequency (parameter) for inspiratory time. Movement of the diaphragm at inspiratory and expiratory phases are also observed …
- 0 views
- 19 Feb, 2024
Observational Study in Diagnosed Patients COVID-19 Supported on an Outpatient Basis. (COVID-PSL)
Given the novelty of this infection, several questions remain: What are all the symptoms that can be contracted by a COVID-19 patient? Are there clinical forms not described? What is the evolutionary profile, the healing time of this disease in patients treated on an outpatient basis?
- 0 views
- 19 Feb, 2024
Better Delineation of YY1 Related Phenotype and Epigenetic Signatures.
Physician that will participate will fill an Excel sheet regarding the clinical and neuropsychological assessment. The investigators will be also happy to have either CD-ROM or a link to have access to the brain MRI data as well as a DNA sample with a minimum 0.5ug of peripheral blood genomic …
- 0 views
- 19 Feb, 2024
Change of Gut Microbiome in the Treatment of Graves' Disease
Primary endpoint is the changes of analyzed gut microbiome before and after ATD treatment. Secondary outcome is to find species that can be used as a biomarker to differentiate the patients refractory to ATD.
- 0 views
- 19 Feb, 2024
Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.
Depending on the country, contact subjects considered to be at high or moderate risk of SARS-CoV-2 are, either isolated at home for a period of time defined by the health authorities or, on the contrary, continue their professional activity on the condition that they adopt measures to prevent transmission to …
- 0 views
- 19 Feb, 2024
Temporal Disorders in Left and Right Brain-Damaged Patients
Aims of this study are to investigate: i) the performance (in terms of accuracy and reaction times) of LBD and RBD patients on Mental Time Travelling; ii) the correlation between Mental Time Travelling and Time Estimation abilities; iii) the efficacy of a single session of PA inducing a leftward (L-PA) …
- 0 views
- 19 Feb, 2024
- 1 location